SCHEDULE 13D/A: Jack W. Schuler Increases Stake in Biodesix Inc. to 24.7% Through Recent Share Purchases

Jack W. Schuler, along with his associated trusts, has significantly increased his beneficial ownership in Biodesix Inc. to approximately 24.7% of outstanding shares through recent open market purchases.

Summary

• Jack W. Schuler, through the Jack W. Schuler Living Trust, purchased an aggregate of 4,723,239 shares of Biodesix Inc. common stock in open market transactions on May 16, 2025, and May 19, 2025.
• The May 16, 2025, purchase involved 4,000,000 shares at prices ranging from $0.2215 to $0.3397, with a weighted average price of $0.2675 per share.
• The May 19, 2025, purchase involved 723,239 shares at prices ranging from $0.2997 to $0.36, with a weighted average price of $0.341 per share.
• These purchases were funded by Mr. Schuler's personal funds.
• As of the filing date, Mr. Schuler beneficially owns 36,332,985 shares, representing approximately 24.7% of Biodesix Inc.'s outstanding common stock.
• This beneficial ownership includes 414,811 shares Mr. Schuler has the right to acquire within 60 days (83,152 from options and 331,659 from vested RSUs).
• The Jack W. Schuler Living Trust holds 20,918,174 shares (14.3% of outstanding shares).
• The Jack W. Schuler 2025 GRAT holds 15,000,000 shares (10.2% of outstanding shares), following a transfer of these shares from the Trust on January 29, 2025, for no additional consideration.
• The beneficial ownership percentages are calculated based on 146,563,031 shares outstanding as of May 7, 2025, as reported in the Issuer's Form 10-Q filed on May 13, 2025, plus shares Mr. Schuler has the right to acquire.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant increase in insider ownership by a major investor, indicating strong confidence in the company's future. This is generally viewed favorably by the market.

Positives

• Significant increase in insider ownership by Jack W. Schuler, a key investor, signaling strong confidence in the company's future prospects.
• The recent open market purchases demonstrate a direct financial commitment from a major beneficial owner.

Future Outlook

This Schedule 13D filing primarily details changes in beneficial ownership and does not provide forward-looking statements or guidance from the company's management regarding future performance or strategic direction.

Industry Context

This filing is specific to an individual's investment activities and does not provide broader industry context or trends. It reflects a significant insider's increased stake in a biotechnology company, which can be interpreted as a vote of confidence in the company's specific trajectory within the industry.

Stakeholder Impact

• Shareholders: Increased insider ownership may instill greater confidence among existing and potential shareholders, potentially leading to positive market perception and share price support.
• Management: The increased stake by a significant investor like Mr. Schuler could imply closer oversight or strategic alignment, potentially influencing future corporate decisions.

Key Dates

Recommendation

Keywords

Biodesix Inc., Jack W. Schuler, Schedule 13D, Insider Ownership, Stock Purchase, Beneficial Ownership, Common Stock, SEC Filing, Investment, Trust, GRAT